Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D00PIE
|
||||
| Former ID |
DIB004657
|
||||
| Drug Name |
Banoxantrone
|
||||
| Synonyms |
AQ4; AQ4M; AQ4N; AZD-1689; AQ4N, AstraZeneca/Novacea
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Acute lymphoblastic leukemia [ICD9: 204.0, 556; ICD10:C91.0] | Discontinued in Phase 1 | [545759] | ||
| Company |
KuDOS Pharmaceuticals; Novacea
|
||||
| Formula |
C22H28N4O6
|
||||
| Canonical SMILES |
c12c(C(=O)c3c(C1=O)c(ccc3O)O)c(ccc2NCC[N+]([O-])(C)C)NC<br />C[N+]([O-])(C)C
|
||||
| CAS Number |
CAS 136470-65-0
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | DNA topoisomerase II | Target Info | Modulator | [1572591] | |
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.